Answers are grounded in this paper and cite their sources.
Narrative review reveals complex polymicrobial interactions within cystic fibrosis lung infections, highlighting the need for targeted microbiome-based therapies.
Although cystic fibrosis pulmonary infection is polymicrobial, routine laboratory methods focus on the detection of a small number of known pathogens. Recently, the use of strict anaerobic culture techniques and molecular technologies have identified other potential pathogens including anaerobic bacteria. Determining the role of all bacteria in a complex bacterial community and how they interact is extremely important; individual bacteria may affect how the community develops, possess virulence factors, produce quorum-sensing signals, stimulate an immune response or transfer antibiotic resistance genes, which could all contribute to disease progression. There are many challenges to managing cystic fibrosis lung infection but as knowledge about the airway microbiome continues to increase, this may lead to advances in the therapeutic management of the disease.
No takes yet. Share an insight, caveat, or question.
Gillanders et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: